Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
September 27th, 2017
We describe here methods for neonatal capsaicin treatment to induce atopic dermatitis in rats and exposure of vaporized formaldehyde to investigate the effects of formaldehyde inhalation on atopic dermatitis.
The overall goal of this procedure is to induce atopic dermatitis-like symptoms by neonatal capsaicin treatment. And to measure the effect of formaldehyde on atopic dermatis-like symptoms. This method can help answer a key question related to the pathophysiological of atopic dermatitis in the dermatological field.
The major advantage of this technique are the induction of atopic dermatitis-like symptoms and the establishment of an important exposure system with the increments. To prepare five milligrams per milliliter capsaicin solution add one milliliter of Tween 80, one milliliter of 100%ethanol and 50 milligrams of capsaicin to a 15 milliliter conical tube. Then add eight milliliters of normal saline to the conical tube.
Cap and shake the tube vigorously until no separated layers are visible. It is critical to deliver the capsaicin between 12 to 48 hours after birth. Inject the capsaicin solution into the subcutaneous tissue on the midline and backside of the neck of a neonatal Sprague Dawley Rat.
To prevent respiratory arrest due to the capsaicin injection place the neonates in an oxygen chamber until respiration becomes normal. If necessary push the chest of neonates to encourage breathing. Begin by preparing plastic chambers equipped with a mirror to allow for full coverage for viewing and holes to allow the rats to breath.
Place the rats in the plastic chamber and cover the ceiling of the chamber with a heavy object to prevent the lid from opening. Then set up a digital video camera to simultaneously record both the mirror views and front views of the rats. Then record the spontaneous behaviors of the rats for one hour.
Play back the video clips and count the number of scratching behaviors such as those exhibited by the rat on the right. And the rat in the center. To score the lesions identify the extent and severity of dermatitis in the ears and other parts of an anesthetized rat.
Define the unit size for the extent of skin lesions as 0.25 centimeters squared. And the severity of skin lesions using this table. Prepare an acrylic glass box that has two connectors on opposite sides.
For circulation of formaldehyde gas the venting outlet should be placed higher than the gas intake outlet. Connect tubes to both connectors. Run the venting outlet tube to the circulation hood or outside of the building for emission of the gas.
And connect the other inlet tube to a medical oxygen regulator. Place a conventional rat cage inside the acrylic glass box. Put one week old rats in the cage and then seal the acrylic glass box as tightly as possible to prevent gas leakage.
Apply cling film to wrap the chamber and close the chamber with a rubberized lid for tight sealing. Add 0.5%formaldehyde solution to the humidifier bottle connected to the medical oxygen regulator. Don't forget that working in formaldehyde can be extremely hazardous.
And precaution such as masks and gloves should always be taken by performing this procedure. Next turn on the regulator and set the flow rate to five liters per minute. Expose the rats to formaldehyde gas for a two hour period.
Shown here are representative photographs of skin inflammation in the capsaicin-treated rat. The chronological development of dermatitis of the capsaicin-treated rats is shown here. This image shoes the chronological development of scratching behaviors in the capsaicin-treated rats.
This is a representative image of relapsing skin lesions of 16 week old capsaicin-treated rats. Serum IgE levels are significantly elevated in capsaicin-treated animals. Significant elevation of IL-4 mRNA expression is also observed in capsaicin-treated animals.
Significant elevation of IL-13 mRNA expression in capsaicin-treated animals is shown here. These representative photographs show atopic dermatitis after the fifth week of treatment using 1.2 parts per million. And 0.8 parts per million formaldehyde compared to controlled treatment with air.
Exposure to 1.2 parts per million formaldehyde but not 0.8 parts per million formaldehyde significantly exacerbated pruritis in the capsaicin-treated atopic dermatitis model. Similar results were observed when dermatitis was measured. Increased serum IgE levels were observed in the capsaicin-treated AD rat model treated with 1.2 parts per million formaldehyde exposure.
Following this procedure other materials like gylcol solution can be used to answer additional questions related to the effects of particular matter on atopic dermatitis. After these developments this technique paved the way for researchers in the field of dermatology to explore the role of environmental factors in the pathogenesis of atopic dermatitis.
View the full transcript and gain access to thousands of scientific videos
Overview
This article describes methods for inducing atopic dermatitis-like symptoms in rats through neonatal capsaicin treatment and investigating the effects of formaldehyde inhalation. The study aims to enhance understanding of the pathophysiology of atopic dermatitis.
Key Study Components
Area of Science
- Dermatology
- Neuroscience
- Toxicology
Background
- Atopic dermatitis is a common skin condition.
- Capsaicin treatment can mimic atopic dermatitis symptoms.
- Formaldehyde exposure is a potential environmental trigger.
- Understanding these interactions is crucial for dermatological research.
Purpose of Study
- To induce atopic dermatitis-like symptoms in a rat model.
- To assess the impact of formaldehyde on these symptoms.
- To explore the underlying mechanisms of atopic dermatitis.
Methods Used
- Neonatal capsaicin treatment to induce symptoms.
- Exposure to vaporized formaldehyde.
- Preparation of capsaicin solution with Tween 80 and ethanol.
- Measurement of atopic dermatitis-like symptoms in rats.
Main Results
- Successful induction of atopic dermatitis-like symptoms.
- Establishment of a formaldehyde exposure system.
- Insights into the pathophysiological mechanisms.
- Potential implications for understanding environmental triggers.
Conclusions
- The methods provide a reliable model for studying atopic dermatitis.
- Formaldehyde exposure may exacerbate symptoms.
- Further research is needed to explore long-term effects.
Frequently Asked Questions
Executive Industry Relevance
Environmental triggers in atopic dermatitis remain a critical unknown in translational dermatology, impacting predictive confidence for therapeutic development. This rat model enables systematic evaluation of environmental exposures, such as formaldehyde, on disease progression and biomarker response. The approach supports mechanistic de-risking and informs early-stage portfolio decisions for dermatology pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of environmental contributions to atopic dermatitis pathogenesis.
- Supports functional validation of disease-relevant pathways through controlled exposure studies.
- Facilitates mechanistic de-risking by linking environmental factors to biomarker changes.
- Provides a platform for hypothesis-driven target selection in dermatology research.
Screening & Assay Development
- Establishes a reproducible animal model for evaluating candidate interventions against environmental exacerbation.
- Standardizes quantitative scoring of dermatitis severity and behavioral endpoints.
- Enables robust measurement of serum IgE and cytokine mRNA as translational biomarkers.
- Prepares validated systems for downstream compound screening and efficacy assessment.
Translational & Preclinical Research
- Aligns animal model outputs with human disease biomarkers such as IgE and cytokine profiles.
- Supports continuity from environmental risk factor discovery to preclinical intervention studies.
- Enables risk-adjusted advancement of dermatology assets based on environmental sensitivity data.
- Provides predictive value for environmental modulation of disease phenotypes.
Pipeline & Workflow Integration
This model bridges early discovery and preclinical validation by enabling controlled hypothesis testing of environmental factors in atopic dermatitis progression.
- Discovery Biology: Supports hypothesis-driven testing of environmental triggers and their mechanistic impact on disease pathways.
- Screening: Delivers standardized, quantitative readouts for severity and biomarker response to exposures.
- Analytics: Provides measurable outputs such as lesion scoring, scratching frequency, and serum biomarker quantification.
- Translational Research: Aligns animal model findings with human-relevant biomarkers for preclinical continuity.
- Enterprise Reuse: Offers a reusable platform for evaluating additional environmental agents or candidate therapeutics.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in environmental risk factor validation and mechanistic understanding.
- Operational Value: Delivers standardized, reproducible protocols for cross-study comparability.
- Strategic Value: Informs go/no-go decisions for dermatology assets sensitive to environmental modulation.
- Portfolio Impact: Enables risk-adjusted prioritization of targets and interventions based on environmental susceptibility.
Implementation Considerations
- Requires expertise in animal handling, dermatological scoring, and environmental exposure systems.
- Needs access to controlled exposure chambers and quantitative behavioral analysis tools.
- Demands rigorous cross-team standardization for lesion scoring and biomarker assays.
- Adaptation may be needed for other environmental agents or disease models.
- Safety protocols are essential due to hazardous formaldehyde handling requirements.
Biopharma FAQs
Chapters in this video
0:05
Title
0:43
Induction of Atopic Dermatitis (AD) by Neonatal Capsaicin Treatment
1:48
Measurement of Pruritus by Counting Spontaneous Scratching Behavior
2:53
Exposure of Animals to Gaseous Formaldehyde
4:22
Results: Capsaicin and Formaldehyde Treatment Induces and Aggravates Relapsing AD-line Skin Inflammation and Pruritus in Rats
6:11
Conclusion
